Cargando…

Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019

BACKGROUND: High fasting plasma glucose (FPG) has been listed as one of the risk factors for bladder cancer. We here estimated the global, regional, and national levels of bladder cancer burden attributable to high FPG from 1990 to 2019. METHODS: Bladder cancer data attributable to high FPG were ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ying, Deng, Yujiao, Dai, Zhijun, Ma, Yubo, Lyu, Lijuan, Lei, Chen, Zheng, Yi, Li, Yizhen, Wang, Ziming, Gao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469723/
https://www.ncbi.nlm.nih.gov/pubmed/37350559
http://dx.doi.org/10.1002/cam4.6219
_version_ 1785099506658836480
author Wu, Ying
Deng, Yujiao
Dai, Zhijun
Ma, Yubo
Lyu, Lijuan
Lei, Chen
Zheng, Yi
Li, Yizhen
Wang, Ziming
Gao, Jie
author_facet Wu, Ying
Deng, Yujiao
Dai, Zhijun
Ma, Yubo
Lyu, Lijuan
Lei, Chen
Zheng, Yi
Li, Yizhen
Wang, Ziming
Gao, Jie
author_sort Wu, Ying
collection PubMed
description BACKGROUND: High fasting plasma glucose (FPG) has been listed as one of the risk factors for bladder cancer. We here estimated the global, regional, and national levels of bladder cancer burden attributable to high FPG from 1990 to 2019. METHODS: Bladder cancer data attributable to high FPG were extracted from the Global Burden of Disease Study 2019, and analyzed by age, sex, year, and location. Age‐standardized rates were utilized to evaluate the burden between different populations. The temporal trend of the burden was estimated through the Joinpoint analysis. RESULTS: In 2019, high FPG contributed to 22,823.33 (95% uncertainty interval [UI], 4694.88–48,962.26) deaths and 399,654.91 (95% UI, 81,609.35–865,890.95) disability‐adjusted life years (DALYs) of bladder cancer globally. Since 1990, the global age‐standardized death and DALY rates of bladder cancer attributable to high FPG increased apparently by 39.18% and 41.48%, respectively. During the last 30 years, high FPG‐related age‐standardized death and DALY rates of bladder cancer have increased in all countries. In 2019, Central Europe showed the greatest high FPG‐related age‐standardized death and DALY rates of bladder cancer, but Andean Latin America had the lowest rates. Nationally, Lebanon showed the greatest high FPG‐related age‐standardized death and DALY rates of bladder cancer in 2019. High FPG‐attributable deaths and DALYs of bladder cancer were more considerable among males and older people. Countries with high SDI showed higher levels of age‐standardized death and DALY rates of bladder cancer due to high FPG and presented remarkable upward trends in rates in the last 30 years. CONCLUSIONS: Globally, the high FPG‐associated bladder cancer burden has remarkably increased in all countries, and showed a higher level among countries with higher SDI. Monitoring FPG levels among patients with bladder cancer is critical to lower the corresponding burden.
format Online
Article
Text
id pubmed-10469723
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104697232023-09-01 Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019 Wu, Ying Deng, Yujiao Dai, Zhijun Ma, Yubo Lyu, Lijuan Lei, Chen Zheng, Yi Li, Yizhen Wang, Ziming Gao, Jie Cancer Med RESEARCH ARTICLES BACKGROUND: High fasting plasma glucose (FPG) has been listed as one of the risk factors for bladder cancer. We here estimated the global, regional, and national levels of bladder cancer burden attributable to high FPG from 1990 to 2019. METHODS: Bladder cancer data attributable to high FPG were extracted from the Global Burden of Disease Study 2019, and analyzed by age, sex, year, and location. Age‐standardized rates were utilized to evaluate the burden between different populations. The temporal trend of the burden was estimated through the Joinpoint analysis. RESULTS: In 2019, high FPG contributed to 22,823.33 (95% uncertainty interval [UI], 4694.88–48,962.26) deaths and 399,654.91 (95% UI, 81,609.35–865,890.95) disability‐adjusted life years (DALYs) of bladder cancer globally. Since 1990, the global age‐standardized death and DALY rates of bladder cancer attributable to high FPG increased apparently by 39.18% and 41.48%, respectively. During the last 30 years, high FPG‐related age‐standardized death and DALY rates of bladder cancer have increased in all countries. In 2019, Central Europe showed the greatest high FPG‐related age‐standardized death and DALY rates of bladder cancer, but Andean Latin America had the lowest rates. Nationally, Lebanon showed the greatest high FPG‐related age‐standardized death and DALY rates of bladder cancer in 2019. High FPG‐attributable deaths and DALYs of bladder cancer were more considerable among males and older people. Countries with high SDI showed higher levels of age‐standardized death and DALY rates of bladder cancer due to high FPG and presented remarkable upward trends in rates in the last 30 years. CONCLUSIONS: Globally, the high FPG‐associated bladder cancer burden has remarkably increased in all countries, and showed a higher level among countries with higher SDI. Monitoring FPG levels among patients with bladder cancer is critical to lower the corresponding burden. John Wiley and Sons Inc. 2023-06-23 /pmc/articles/PMC10469723/ /pubmed/37350559 http://dx.doi.org/10.1002/cam4.6219 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Wu, Ying
Deng, Yujiao
Dai, Zhijun
Ma, Yubo
Lyu, Lijuan
Lei, Chen
Zheng, Yi
Li, Yizhen
Wang, Ziming
Gao, Jie
Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
title Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
title_full Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
title_fullStr Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
title_full_unstemmed Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
title_short Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019
title_sort estimates of bladder cancer burden attributable to high fasting plasma glucose: findings of the global burden of disease study 2019
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469723/
https://www.ncbi.nlm.nih.gov/pubmed/37350559
http://dx.doi.org/10.1002/cam4.6219
work_keys_str_mv AT wuying estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT dengyujiao estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT daizhijun estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT mayubo estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT lyulijuan estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT leichen estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT zhengyi estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT liyizhen estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT wangziming estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019
AT gaojie estimatesofbladdercancerburdenattributabletohighfastingplasmaglucosefindingsoftheglobalburdenofdiseasestudy2019